Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet

NCT ID: NCT05630703

Last Updated: 2025-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to compare the effect of mindfulness-based awareness training in Irritable Bowel Syndrome (IBS) (MB-IBS-EAT) with the dietary standard of care (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet) on patient's IBS symptoms

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This pilot study will be a randomized parallel trial comparing MB-IBS-EAT done over an 8-week period to a standard low FODMAP diet. The low FODMAP diet is currently employed by clinicians as a treatment for IBS, but response rates are poor, without documented long-term benefit. This finding supports the need for better, longer lasting interventions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome (IBS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The randomization scheme used will be a random number generator using the Research Randomizer website (https://www.randomizer.org/) where the subjects will be randomized in one (1) of two (2) arms:

Mindfulness-based Awareness Training in IBS (MB-IBS-EAT) Intervention OR Low FODMAP Diet Intervention
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators
The principal investigator will be blinded for the duration of the study. The study psychologist and the dietician will be blinded to the study results for the duration of the study.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Mindfulness Training

Behavioral: Mindfulness-based Eating Awareness Training in IBS - The MB-IBS-EAT is an 8-week intervention with weekly 1-hour sessions in a web-based group format.

Group Type EXPERIMENTAL

Mindfulness-based Attention Training in IBS

Intervention Type BEHAVIORAL

The MB-IBS-EAT is an 8-week intervention with weekly 1-hour sessions in a web-based group format.

fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet

Dietary: Low FODMAP Diet - Subjects in the FODMAP group will be provided dietary instructions by a registered dietician during weekly 1-hour sessions in a web-based group format.

Group Type ACTIVE_COMPARATOR

Low FODMAP Diet

Intervention Type OTHER

Subjects in the FODMAP group will be provided dietary instructions by a registered dietician during weekly 1-hour sessions in a web-based group format

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mindfulness-based Attention Training in IBS

The MB-IBS-EAT is an 8-week intervention with weekly 1-hour sessions in a web-based group format.

Intervention Type BEHAVIORAL

Low FODMAP Diet

Subjects in the FODMAP group will be provided dietary instructions by a registered dietician during weekly 1-hour sessions in a web-based group format

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Dietary Intervention

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 and over
* Meets Rome IV criteria for diagnosis of Irritable Bowel Syndrome (IBS)
* Has legal and mental capacity to understand and sign an informed consent document
* Access to a computer or smart device with internet

Exclusion Criteria

* Pregnancy
* Active malignancy in the previous five years
* Current or prior history of alcohol or drug abuse as defined by clinician
* Any history of eating disorder such as anorexia or bulimia
* Taking yoga or with prior history of mindfulness therapy within 3 months of enrollment
* Currently on a fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet
* Psychiatric illnesses other than depression or anxiety disorder
* Nausea or vomiting
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wake Forest University Health Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Baharak Moshiree, MD

Role: PRINCIPAL_INVESTIGATOR

Wake Forest University Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Atrium Health Gastroenterology and Hepatology Morehead Medical Plaza

Charlotte, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jamie Crawford, RN, BSN

Role: CONTACT

704-355-0282

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jamie Crawford, RN, BSN

Role: primary

704-355-0282

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07-19-15E

Identifier Type: OTHER

Identifier Source: secondary_id

IRB00083217

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Psychological and Dietary Treatment in IBS
NCT04770883 NOT_YET_RECRUITING NA